ALG10 and neoplasm: We found that the tumorigenic ability of CRC cells with ALG10 knockdown was decreased, which was evident by the decreased tumor-formation rate (Figure 3A and 3B, Figure 3E and 3F) and stem cell frequency using the tumor-limiting dilution assay (Figure 3C and 3G).